Teleflex Stock News

Teleflex, Inc. (NYSE:TFX ) Q2 2022 Earnings Conference Call July 28, 2022 8:00 AM ET Company Participants Lawrence Keusch - VP, IR & Strategy Development Liam Kelly - Chairman, President & CEO Thomas

Teleflex (TFX) delivered earnings and revenue surprises of 1.19% and 2.32%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

WAYNE, Pa., July 14, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its second quarter financial results and provide an operational update at 8:00 a.m

Investors are optimistic about Teleflex's (TFX) better-than-expected results and strong growth within the vascular business.

Teleflex (TFX) exhibits year-over-year growth across the Americas, EMEA and Asia regions at CER in the first quarter.

Teleflex Incorporated (NYSE:TFX ) Q1 2022 Earnings Conference Call April 28, 2022 8:00 AM ET Company Participants Lawrence Keusch - VP, Investor Relations and Strategy Development Liam Kelly - Chairma

WAYNE, Pa., April 26, 2022 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Bank of America Securities 2022 Healthcare Confe

WAYNE, Pa., April 14, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its first quarter 2022 results, and provide an operational update at 8:00 a.m. Ea

Teleflex: Diversified Portfolio Of Medical Devices At A Convenient Stock Price

SAN FRANCISCO , March 11, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Central Venous Catheters (CVCs) - Global Market Trajectory & Analytics" . The report presents fresh perspectives on opportunities and challenges in a significantly transformed post COVID-19 marketplace. FACTS AT A GLANCE What''s New for 2022? Global competitiveness and key competitor percentage market shares Market presence across multiple geographies - Strong/Active/Niche/Trivial Online interactive peer-to-peer collaborative bespoke updates Access to our digital archives and MarketGlass Research Platform Complimentary updates for one year Edition: 7; Released: February 2022 Executive Pool: 4019 Companies: 61 - Players covered include Amecath; AngioDynamics Inc.; B. Braun Melsungen AG; Bactiguard AB; Becton, Dickinson and Company; COOK MEDICAL LLC; Edwards Lifesciences Corporation; Guangdong Baihe Medical Technology Co., Ltd; ICU Medical, Inc.; Insung Medical Co.

Teleflex (TFX) continues to face supply-chain challenges and freight logistic delays.

WAYNE, Pa., March 09, 2022 (GLOBE NEWSWIRE) -- Thomas Powell, Executive Vice President and Chief Financial Officer, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the KeyBanc Life Science

Teleflex Incorporated found using ticker (TFX) have now 9 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 455 and 325 with a mean TP of 408.56. Given that the stocks previous close was at 343.32 this is indicating there is a potential upside of 19.0%. The 50 day moving average now sits at 323.81 and the 200 moving average now moves to 361.13. The company has a market capitalisation of $16,395m. Find out more information at: https://www.teleflex.com [stock_market_widget type="chart" template="basic" color="green" assets=TFX" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $19,510m based on the market concensus. Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

WAYNE, Pa., March 02, 2022 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 43 rd Annual Raymond James Institutional Investors Conference at the JW Marriott Orlando Grande Lakes, Orlando, FL, on Tuesday, March 8, 2022, at 9:15 a.m. (ET).

WAYNE, Pa., March 02, 2022 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 43rd Annual Raymond James Institutional Investor